Screening and Treating Adults for Lipid Disorders: Summary of the Evidence. Screening and Treating Adults for Lipid Disorders: Summary of the Evidence, Table 1

You Are Here: AHRQ Home > Clinical Information > U.S. Preventive Services Task Force (USPSTF) > New Recommendations Issued for Preventive Services > Screening and Treating Adults for Lipid Disorders: Summary of the Evidence

Table 1. Accuracy of Different Measures of Coronary Heart Disease Risk

Test	Area under ROC Curve^a (±SD)
Framingham-based global risk assessment	0.85 (±0.02)
NCEP ATP II^b	0.74 (±0.03)
TC/HDL ratio^c	0.72 (±0.04)
TC alone	0.68 (±0.03)

^[a] ROC indicates receiver operating characteristic; data from Grover et al. (22)
^[b] National Cholesterol Education Program, Adult Treatment Panel II.
^[c] TC indicates total cholesterol. HDL indicates high-density lipoprotein cholesterol.

Return to Document